Abstract:Objective:To explore the diversity and community difference of microbial flora in bronchoalveolar lavage fluid (BALF) of patients with pneumonic-type lung cancer and clinical significance.Methods:A retrospective study was performed in BALF collected from 9 patients with pneumonic-type lung cancer, 11 patients with early nodular-type (maximum lesion diameter ≤ 3 cm) lung cancer and 7 healthy people.The total DNA of BALF flora was extracted.16s rRNA gene was amplified by universal primers, and 16s bacteria were sequenced through high-throughput second-generation sequencing (NGS) analysis of the rRNA gene (V3-V4). The differences of microflora abundance and distribution characteristics were analyzed and compared among the three groups. Receiver operating characteristic (ROC) curves were plotted to estimate the prediction value in diagnosis of pneumonic-type lung cancer.Results:The median total copy number of bacterial sequences in BALF of pneumonic-type group was 9 235(3 498, 30 743), which was higher than that of control group (382[98, 2 508]) and nodular-type group (486[96, 780])(both P=0.001). The median number of bacterial species was [ 9(6.5, 10.5)] in the pneumonic group, which was higher than the control group (2[2, 6]) and the nodule-type group (4[2, 7])( P=0.015, 0.021). The frequencies of Streptococcus pneumoniae and Prevotella were (9/9, 100.0%), (8/9, 88.9%), which were significantly higher than those of the control group (3/7, 42.9%), (2/7, 28.6%) and the nodule-type group (4/11, 36.4%), (4/11, 36.4%)(both P<0.05). Prevotella melaninogenica were detected in 8 patients (8/9, 88.9%)in the pneumonic-type group, 3 patients in nodular-type group (3/11, 27.3%) and 1 patient (1/7, 14.3%) in control group (both P<0.01). The median copy number of Prevotella melaninogenica (2 392[521.3, 11 715]) was significantly higher than that of control group (219) and nodular-type group (48[9-498])(both P<0.05). Taking Prevotella sequence number 37.3% or Prevotella melaninogenica sequence number 263 as the critical value, ROC analysis showed that the areas under ROC curve (AUC) for the predictive value of diagnosis of pneumonic-type lung cancer were 0.84(0.663, 1.000, P=0.004 7) and 0.92(0.785 2, 1.000, P=0.005) respectively. Conclusions:The diversity of microbial flora in the lower respiratory tract of patients with pneumonic-type lung cancer is more complex and the distribution of genera composition is different from local early lung cancer and healthy control group.The increase and dominance of Prevotella and Prevotella melaninogenica showed some potential predictive value in the diagnosis of pneumonic-type lung cancer.

A Preliminary Study of Microbiota Diversity in Saliva and Bronchoalveolar Lavage Fluid from Patients with Primary Bronchogenic Carcinoma

Characterization of the lung microbiome and exploration of potential bacterial biomarkers for lung cancer

Difference Of Lower Airway Microbiome In Bilateral Protected Specimen Brush Between Lung Cancer Patients With Unilateral Lobar Masses And Control Subjects

The Microbiome of Lower Respiratory Tract and Tumor Tissue in Lung Cancer Manifested As Radiological Ground-Glass Opacity

Diminishing Microbiome Richness and Distinction in the Lower Respiratory Tract of Lung Cancer Patients: A Multiple Comparative Study Design with Independent Validation.

Microbiome features and clinical significance in bronchoalveolar lavage fluid of patients with pneumonic-type lung cancer

Comparative analysis of the lung microbiota in patients with respiratory infections, tuberculosis, and lung cancer: A preliminary study

Microbiota Core in Central Lung Cancer with Streptococcal Enrichment as a Possible Diagnostic Marker

A Preliminary Study on Microbiota Characteristics of Bronchoalveolar Lavage Fluid in Patients with Pulmonary Nodules Based on Metagenomic Next-Generation Sequencing

Diagnostic Value of the Microbiome in the Bronchoalveolar Fluid of Patients with Lung masses and its Relationship with their Clinical Features

The Composition Alteration of Respiratory Microbiota in Lung Cancer

Airway Microbiota in Patients With Synchronous Multiple Primary Lung Cancer: The Bacterial Topography of the Respiratory Tract

Biogeography of the Respiratory Tract Microbiome in Patients With Malignant Tracheal Tumors

Prediction of lung cancer using novel biomarkers based on microbiome profiling of bronchoalveolar lavage fluid

Lung microbiome alterations in NSCLC patients

Characterization of Microbiota in Cancerous Lung and the Contralateral Non-Cancerous Lung Within Lung Cancer Patients

Dysbiosis of the Salivary Microbiome Is Associated With Non-smoking Female Lung Cancer and Correlated With Immunocytochemistry Markers

Alterations of lower respiratory tract microbiome and short-chain fatty acids in different segments in lung cancer: a multiomics analysis

The Composition of Microbiome in Larynx and the Throat Biodiversity between Laryngeal Squamous Cell Carcinoma Patients and Control Population.

[Analysis of gut microbiome in patients with lung adenocarcinoma and lung squamous cell carcinoma]

The airway microbiota of non‐small cell lung cancer patients and its relationship to tumor stage and EGFR gene mutation